Usana Health Sciences (USNA) Gross Profit (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Gross Profit data on file, last reported at $190.8 million in Q2 2026.

• On a quarterly basis, Gross Profit fell 3.2% year-over-year to $190.8 million in Q2 2026; TTM through Apr 2026 was $718.1 million, a 1.76% increase from a year earlier, with the FY2026 full-year figure at $724.4 million, up 4.49% from the prior year.
• Gross Profit for Q2 2026 stood at $190.8 million, up from $176.8 million in the prior quarter.
• Over the last five years, Gross Profit for USNA reached as high as $294.5 million in Q1 2022 and fell as low as $161.0 million in Q3 2024.
• Historically, Gross Profit has averaged $191.8 million across 5 years, with a median of $185.2 million in 2024.
• Across the five-year window, Gross Profit plunged 38.37% in 2022 and climbed 7.61% in 2025, its largest moves.
• Year by year, Gross Profit stood at $181.5 million in 2022, then retreated by 1.52% to $178.8 million in 2023, then fell by 2.07% to $175.1 million in 2024, then declined by 5.83% to $164.9 million in 2025, then increased by 15.73% to $190.8 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $190.8 million in Q2 2026, $176.8 million in Q1 2026, and $164.9 million in Q3 2025.